A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in Non-Cirrhotic Subjects with Nonalcoholic Steatohepatitis (NASH)

  • Braude, Michael (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date9/07/24 → 8/07/29

Clinical Trial Phase

  • Phase II